Type I Interferon Signaling Exacerbates Chlamydia muridarum Genital Infection in a Murine Model

Type I interferons (IFNs) induced during in vitro chlamydial infection exert bactericidal and immunomodulatory functions. To determine the precise role of type I IFNs during in vivo chlamydial genital infection, we examined the course and outcome of Chlamydia muridarum genital infection in mice gene...

Full description

Saved in:
Bibliographic Details
Published inInfection and Immunity Vol. 76; no. 10; pp. 4642 - 4648
Main Authors Nagarajan, Uma M, Prantner, Daniel, Sikes, James D, Andrews, Charles W. Jr, Goodwin, Anna M, Nagarajan, Shanmugam, Darville, Toni
Format Journal Article
LanguageEnglish
Published Washington, DC American Society for Microbiology 01.10.2008
American Society for Microbiology (ASM)
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Type I interferons (IFNs) induced during in vitro chlamydial infection exert bactericidal and immunomodulatory functions. To determine the precise role of type I IFNs during in vivo chlamydial genital infection, we examined the course and outcome of Chlamydia muridarum genital infection in mice genetically deficient in the receptor for type I IFNs (IFNAR⁻/⁻ mice). A significant reduction in chlamydial shedding and duration of lower genital tract infection was observed in IFNAR⁻/⁻ mice in comparison to the level of chlamydial shedding and duration of infection in wild-type (WT) mice. Furthermore, IFNAR⁻/⁻ mice developed less chronic oviduct pathology in comparison to that in WT mice. Compared to the WT, IFNAR⁻/⁻ mice had a greater number of chlamydial-specific T cells in their iliac lymph nodes 21 days postinfection. IFNAR⁻/⁻ mice also exhibited earlier and enhanced CD4 T-cell recruitment to the cervical tissues, which was associated with increased expression of CXCL9 in the genital secretions of IFNAR⁻/⁻ mice, but not with expression of CXCL10, which was reduced in the genital secretions of IFNAR⁻/⁻ mice. These data suggest that type I IFNs exacerbate C. muridarum genital infection through an inhibition of the chlamydial-specific CD4 T-cell response.
AbstractList Type I interferons (IFNs) induced during in vitro chlamydial infection exert bactericidal and immunomodulatory functions. To determine the precise role of type I IFNs during in vivo chlamydial genital infection, we examined the course and outcome of Chlamydia muridarum genital infection in mice genetically deficient in the receptor for type I IFNs (IFNAR −/− mice). A significant reduction in chlamydial shedding and duration of lower genital tract infection was observed in IFNAR −/− mice in comparison to the level of chlamydial shedding and duration of infection in wild-type (WT) mice. Furthermore, IFNAR −/− mice developed less chronic oviduct pathology in comparison to that in WT mice. Compared to the WT, IFNAR −/− mice had a greater number of chlamydial-specific T cells in their iliac lymph nodes 21 days postinfection. IFNAR −/− mice also exhibited earlier and enhanced CD4 T-cell recruitment to the cervical tissues, which was associated with increased expression of CXCL9 in the genital secretions of IFNAR −/− mice, but not with expression of CXCL10, which was reduced in the genital secretions of IFNAR −/− mice. These data suggest that type I IFNs exacerbate C. muridarum genital infection through an inhibition of the chlamydial-specific CD4 T-cell response.
ABSTRACT Type I interferons (IFNs) induced during in vitro chlamydial infection exert bactericidal and immunomodulatory functions. To determine the precise role of type I IFNs during in vivo chlamydial genital infection, we examined the course and outcome of Chlamydia muridarum genital infection in mice genetically deficient in the receptor for type I IFNs (IFNAR −/− mice). A significant reduction in chlamydial shedding and duration of lower genital tract infection was observed in IFNAR −/− mice in comparison to the level of chlamydial shedding and duration of infection in wild-type (WT) mice. Furthermore, IFNAR −/− mice developed less chronic oviduct pathology in comparison to that in WT mice. Compared to the WT, IFNAR −/− mice had a greater number of chlamydial-specific T cells in their iliac lymph nodes 21 days postinfection. IFNAR −/− mice also exhibited earlier and enhanced CD4 T-cell recruitment to the cervical tissues, which was associated with increased expression of CXCL9 in the genital secretions of IFNAR −/− mice, but not with expression of CXCL10, which was reduced in the genital secretions of IFNAR −/− mice. These data suggest that type I IFNs exacerbate C. muridarum genital infection through an inhibition of the chlamydial-specific CD4 T-cell response.
Type I interferons (IFNs) induced during in vitro chlamydial infection exert bactericidal and immunomodulatory functions. To determine the precise role of type I IFNs during in vivo chlamydial genital infection, we examined the course and outcome of Chlamydia muridarum genital infection in mice genetically deficient in the receptor for type I IFNs (IFNAR super(-/-) mice). A significant reduction in chlamydial shedding and duration of lower genital tract infection was observed in IFNAR super(-/-) mice in comparison to the level of chlamydial shedding and duration of infection in wild-type (WT) mice. Furthermore, IFNAR super(-/-) mice developed less chronic oviduct pathology in comparison to that in WT mice. Compared to the WT, IFNAR super(-/-) mice had a greater number of chlamydial-specific T cells in their iliac lymph nodes 21 days postinfection. IFNAR super(-/-) mice also exhibited earlier and enhanced CD4 T-cell recruitment to the cervical tissues, which was associated with increased expression of CXCL9 in the genital secretions of IFNAR super(-/-) mice, but not with expression of CXCL10, which was reduced in the genital secretions of IFNAR super(-/-) mice. These data suggest that type I IFNs exacerbate C. muridarum genital infection through an inhibition of the chlamydial-specific CD4 T-cell response.
Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue IAI About IAI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy Connect to IAI IAI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0019-9567 Online ISSN: 1098-5522 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to IAI .asm.org, visit: IAI       
Type I interferons (IFNs) induced during in vitro chlamydial infection exert bactericidal and immunomodulatory functions. To determine the precise role of type I IFNs during in vivo chlamydial genital infection, we examined the course and outcome of Chlamydia muridarum genital infection in mice genetically deficient in the receptor for type I IFNs (IFNAR⁻/⁻ mice). A significant reduction in chlamydial shedding and duration of lower genital tract infection was observed in IFNAR⁻/⁻ mice in comparison to the level of chlamydial shedding and duration of infection in wild-type (WT) mice. Furthermore, IFNAR⁻/⁻ mice developed less chronic oviduct pathology in comparison to that in WT mice. Compared to the WT, IFNAR⁻/⁻ mice had a greater number of chlamydial-specific T cells in their iliac lymph nodes 21 days postinfection. IFNAR⁻/⁻ mice also exhibited earlier and enhanced CD4 T-cell recruitment to the cervical tissues, which was associated with increased expression of CXCL9 in the genital secretions of IFNAR⁻/⁻ mice, but not with expression of CXCL10, which was reduced in the genital secretions of IFNAR⁻/⁻ mice. These data suggest that type I IFNs exacerbate C. muridarum genital infection through an inhibition of the chlamydial-specific CD4 T-cell response.
Type I interferons (IFNs) induced during in vitro chlamydial infection exert bactericidal and immunomodulatory functions. To determine the precise role of type I IFNs during in vivo chlamydial genital infection, we examined the course and outcome of Chlamydia muridarum genital infection in mice genetically deficient in the receptor for type I IFNs (IFNAR-/- mice). A significant reduction in chlamydial shedding and duration of lower genital tract infection was observed in IFNAR-/- mice in comparison to the level of chlamydial shedding and duration of infection in wild-type (WT) mice. Furthermore, IFNAR-/- mice developed less chronic oviduct pathology in comparison to that in WT mice. Compared to the WT, IFNAR-/- mice had a greater number of chlamydial-specific T cells in their iliac lymph nodes 21 days postinfection. IFNAR-/- mice also exhibited earlier and enhanced CD4 T-cell recruitment to the cervical tissues, which was associated with increased expression of CXCL9 in the genital secretions of IFNAR-/- mice, but not with expression of CXCL10, which was reduced in the genital secretions of IFNAR-/- mice. These data suggest that type I IFNs exacerbate C. muridarum genital infection through an inhibition of the chlamydial-specific CD4 T-cell response.
Author Darville, Toni
Andrews, Charles W. Jr
Nagarajan, Uma M
Goodwin, Anna M
Sikes, James D
Nagarajan, Shanmugam
Prantner, Daniel
AuthorAffiliation Division of Pediatric Infectious Diseases, Arkansas Children's Hospital Research Institute, Little Rock, Arkansas 72202, 1 Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, 2 Department of Pathology, Rockdale Medical Center, Conyers, Georgia 30012 3
AuthorAffiliation_xml – name: Division of Pediatric Infectious Diseases, Arkansas Children's Hospital Research Institute, Little Rock, Arkansas 72202, 1 Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, 2 Department of Pathology, Rockdale Medical Center, Conyers, Georgia 30012 3
Author_xml – sequence: 1
  fullname: Nagarajan, Uma M
– sequence: 2
  fullname: Prantner, Daniel
– sequence: 3
  fullname: Sikes, James D
– sequence: 4
  fullname: Andrews, Charles W. Jr
– sequence: 5
  fullname: Goodwin, Anna M
– sequence: 6
  fullname: Nagarajan, Shanmugam
– sequence: 7
  fullname: Darville, Toni
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20683334$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/18663004$$D View this record in MEDLINE/PubMed
BookMark eNqF0U1vEzEQBmALFdEPuHGGFRKc2OLvtS9IVVRKpFYc2p6tiXc2Mdr1BnsD5N_jNFGBU0-W5cfj8byn5CiOEQl5zeg5Y9x8ml_MzynV3NbUPCMnjFpTK8X5ETmhlNnaKt0ck9Ocv5etlNK8IMfMaC0olSfE3W3XWM2reZwwdZjGWN2GZYQ-xGV1-Rs8pgVMmKvZqodh2waohk0KLaTNUF1hDBP05XKHfgrlbogVVDcFRKxuxhb7l-R5B33GV4f1jNx_ubybfa2vv13NZxfXtVdcTTVqrWXLkOsGLJb2GhSsBQtaq5YpsAvRNVYIRbWxRntPu9Z63jTUGMmEFWfk877uerMYsPUYpwS9W6cwQNq6EYL7_ySGlVuOPx1XUpuHAh8OBdL4Y4N5ckPIHvseIo6b7LRVDRNMPAk5k1YZZZ6EzGopGruDH_fQpzHnhN1j24y6XcauZOweMnZ0x9_8-9W_-BBqAe8PALKHvksQfciPjpcZCiF27t3ercJy9SskdJAHF8qoGr17WmrJC3q7Rx2MDpapFLq_5ZQJypSkXAnxB3pXxFM
CODEN INFIBR
CitedBy_id crossref_primary_10_1111_aji_13754
crossref_primary_10_1128_mBio_00385_19
crossref_primary_10_1128_IAI_05549_11
crossref_primary_10_1093_infdis_jiz087
crossref_primary_10_3390_ijms222111398
crossref_primary_10_1016_j_imbio_2012_01_010
crossref_primary_10_1128_IAI_00491_09
crossref_primary_10_1093_femspd_ftu028
crossref_primary_10_4049_jimmunol_0901383
crossref_primary_10_1371_journal_pone_0023135
crossref_primary_10_3389_fimmu_2014_00412
crossref_primary_10_4049_jimmunol_0900295
crossref_primary_10_3389_fimmu_2022_1001255
crossref_primary_10_1093_infdis_jiab149
crossref_primary_10_1089_jir_2015_0013
crossref_primary_10_1016_j_vaccine_2021_03_043
crossref_primary_10_1128_JVI_05671_11
crossref_primary_10_1016_j_fertnstert_2012_07_1113
crossref_primary_10_1089_vim_2019_0076
crossref_primary_10_1128_IAI_00768_16
crossref_primary_10_1371_journal_ppat_1006165
crossref_primary_10_1371_journal_pone_0146186
crossref_primary_10_1111_aji_12995
crossref_primary_10_1038_icb_2012_13
crossref_primary_10_1002_JLB_MR0318_122RR
crossref_primary_10_4049_jimmunol_0902065
crossref_primary_10_1371_journal_pone_0010005
crossref_primary_10_4161_viru_1_5_12787
crossref_primary_10_4049_jimmunol_1701658
crossref_primary_10_1128_iai_00153_23
crossref_primary_10_1093_femsre_fuw027
crossref_primary_10_1128_mBio_00979_20
crossref_primary_10_1128_iai_00670_21
crossref_primary_10_4049_jimmunol_1202443
crossref_primary_10_2217_fmb_10_148
crossref_primary_10_3390_cells11010074
crossref_primary_10_1016_j_atherosclerosis_2019_09_021
crossref_primary_10_1128_microbiolspec_MCHD_0012_2015
crossref_primary_10_3389_fimmu_2018_02022
crossref_primary_10_3390_microorganisms9050973
crossref_primary_10_1016_j_immuni_2019_03_025
crossref_primary_10_1016_j_smim_2019_101328
crossref_primary_10_1093_infdis_jiab031
crossref_primary_10_3390_microorganisms10071260
crossref_primary_10_1038_s41586_023_06421_w
crossref_primary_10_1128_IAI_00262_19
crossref_primary_10_1038_s41590_018_0243_7
crossref_primary_10_4049_jimmunol_0903704
crossref_primary_10_1128_IAI_00140_11
crossref_primary_10_3389_fimmu_2014_00431
crossref_primary_10_1016_j_vetimm_2011_05_036
crossref_primary_10_1038_s41598_020_75129_y
crossref_primary_10_1016_j_tim_2021_01_007
crossref_primary_10_4049_jimmunol_1402794
crossref_primary_10_1038_nri3133
crossref_primary_10_1007_s12026_012_8362_y
crossref_primary_10_1111_j_1462_5822_2010_01478_x
crossref_primary_10_1128_mBio_00018_13
crossref_primary_10_4049_jimmunol_0903273
crossref_primary_10_1371_journal_ppat_1006388
crossref_primary_10_1016_j_chom_2022_10_013
crossref_primary_10_1093_femspd_ftab012
crossref_primary_10_1371_journal_ppat_1006383
crossref_primary_10_3390_vaccines5010003
crossref_primary_10_1111_j_1574_695X_2012_00939_x
crossref_primary_10_4049_jimmunol_1001548
crossref_primary_10_4049_jimmunol_1302718
crossref_primary_10_1111_imcb_1033
crossref_primary_10_1128_IAI_01176_10
crossref_primary_10_3390_microorganisms11102449
crossref_primary_10_1155_2017_9361802
crossref_primary_10_1126_science_1233321
crossref_primary_10_1016_j_chom_2009_05_014
crossref_primary_10_2217_fmb_13_80
crossref_primary_10_1016_j_micpath_2019_103950
crossref_primary_10_1111_sji_12107
Cites_doi 10.1016/S0022-1759(01)00446-X
10.4049/jimmunol.169.11.6522
10.1073/pnas.091096998
10.4049/jimmunol.171.11.6187
10.1016/j.micinf.2007.08.010
10.1128/iai.63.12.4661-4668.1995
10.1172/JCI119136
10.1126/science.8009221
10.1128/iai.48.3.847-849.1985
10.1128/iai.31.3.1161-1176.1981
10.1128/iai.64.10.3951-3956.1996
10.1084/jem.20040976
10.1128/IAI.70.2.844-850.2002
10.1128/iai.63.2.516-521.1995
10.1128/iai.63.9.3302-3308.1995
10.1016/j.cell.2007.10.034
10.1128/iai.39.1.362-370.1983
10.1038/nri1684
10.1097/01.olq.0000148299.14513.11
10.1128/IAI.68.12.6879-6882.2000
10.1016/S0070-2153(05)68006-4
10.1128/IAI.72.7.3951-3960.2004
10.1128/iai.65.8.3065-3073.1997
10.1073/pnas.84.16.5888
10.1089/107999001750133131
10.1073/pnas.0607325103
10.1128/iai.60.10.4427-4429.1992
10.4049/jimmunol.177.11.7974
10.4049/jimmunol.172.12.7417
10.1038/icb.1991.49
10.4049/jimmunol.175.1.450
10.4049/jimmunol.167.11.6453
10.4049/jimmunol.180.6.4040
10.1128/IAI.73.12.8226-8236.2005
10.1089/jir.2006.26.699
10.1016/0882-4010(86)90071-9
10.4049/jimmunol.176.11.6982
10.1084/jem.20040712
10.1136/sti.79.6.474
10.1128/IAI.69.6.3556-3561.2001
ContentType Journal Article
Copyright 2008 INIST-CNRS
Copyright © 2008, American Society for Microbiology
Copyright_xml – notice: 2008 INIST-CNRS
– notice: Copyright © 2008, American Society for Microbiology
DBID FBQ
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QL
7T5
C1K
H94
7T7
8FD
FR3
P64
7X8
5PM
DOI 10.1128/IAI.00629-08
DatabaseName AGRIS
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Bacteriology Abstracts (Microbiology B)
Immunology Abstracts
Environmental Sciences and Pollution Management
AIDS and Cancer Research Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
AIDS and Cancer Research Abstracts
Immunology Abstracts
Bacteriology Abstracts (Microbiology B)
Environmental Sciences and Pollution Management
Technology Research Database
Engineering Research Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList
CrossRef
AIDS and Cancer Research Abstracts


Technology Research Database
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: FBQ
  name: AGRIS
  url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1098-5522
EndPage 4648
ExternalDocumentID 10_1128_IAI_00629_08
18663004
20683334
iai_76_10_4642
US201301540253
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: R01 AI067678-01A2
– fundername: NIAID NIH HHS
  grantid: R01 AI054624
– fundername: NIAID NIH HHS
  grantid: AI054624
– fundername: NIAID NIH HHS
  grantid: R01 AI067678
– fundername: NIAID NIH HHS
  grantid: AI067678
GroupedDBID ---
-DZ
-~X
.55
.GJ
0R~
18M
29I
2WC
39C
3O-
4.4
41~
53G
5GY
5RE
5VS
85S
ABOCM
ACGFO
ADBBV
AENEX
AFMIJ
AGCDD
AI.
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
C1A
CS3
D0S
DIK
DU5
E3Z
EBS
EJD
F5P
FBQ
FRP
GX1
HYE
HZ~
H~9
IH2
J5H
KQ8
L7B
MVM
NEJ
O9-
OHT
OK1
P2P
RHF
RHI
RNS
RPM
RSF
SJN
TR2
TWZ
UCJ
UPT
VH1
VQA
W2D
W8F
WH7
WHG
WOQ
X7M
XFK
Y6R
ZA5
ZGI
ZXP
~KM
08R
AAPBV
AAUGY
H13
IQODW
AGVNZ
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QL
7T5
C1K
H94
7T7
8FD
FR3
P64
7X8
5PM
ID FETCH-LOGICAL-c525t-e6664d1e267a9e1867e31da9a665d15a9b3f79335068986cc0fd9c27708841393
IEDL.DBID RPM
ISSN 0019-9567
IngestDate Tue Sep 17 21:01:10 EDT 2024
Sat Oct 26 01:38:27 EDT 2024
Fri Oct 25 03:26:09 EDT 2024
Fri Oct 25 22:45:44 EDT 2024
Thu Sep 12 18:19:00 EDT 2024
Sat Sep 28 07:49:23 EDT 2024
Sun Oct 22 16:09:06 EDT 2023
Wed May 18 15:27:04 EDT 2016
Wed Dec 27 19:20:46 EST 2023
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords Infection
Animal model
Microbiology
Cytokine
Bacteriosis
Chlamydiosis
Interferon
Immunity
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c525t-e6664d1e267a9e1867e31da9a665d15a9b3f79335068986cc0fd9c27708841393
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Corresponding author. Mailing address: Division of Pediatric Infectious Diseases, Arkansas Children's Hospital Research Institute, 1120 Marshall Street, Room 2052, Little Rock, AR 72202. Phone: (501) 364-2479. Fax: (501) 364-2403. E-mail: nagarajanuma@uams.edu
Present address: Department of Pediatrics, University of Pittsburgh Medical Center, Pittsburgh, PA 15213.
Editor: B. A. McCormick
OpenAccessLink https://doi.org/10.1128/iai.00629-08
PMID 18663004
PQID 19643798
PQPubID 23462
PageCount 7
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_2546839
proquest_miscellaneous_69571313
fao_agris_US201301540253
pascalfrancis_primary_20683334
pubmed_primary_18663004
proquest_miscellaneous_21495858
proquest_miscellaneous_19643798
crossref_primary_10_1128_IAI_00629_08
highwire_asm_iai_76_10_4642
PublicationCentury 2000
PublicationDate 2008-10-01
PublicationDateYYYYMMDD 2008-10-01
PublicationDate_xml – month: 10
  year: 2008
  text: 2008-10-01
  day: 01
PublicationDecade 2000
PublicationPlace Washington, DC
PublicationPlace_xml – name: Washington, DC
– name: United States
PublicationTitle Infection and Immunity
PublicationTitleAlternate Infect Immun
PublicationYear 2008
Publisher American Society for Microbiology
American Society for Microbiology (ASM)
Publisher_xml – name: American Society for Microbiology
– name: American Society for Microbiology (ASM)
References 17032164 - J Interferon Cytokine Res. 2006 Oct;26(10):699-705
17030789 - Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15535-9
7591120 - Infect Immun. 1995 Dec;63(12):4661-8
18083102 - Cell. 2007 Dec 14;131(6):1124-36
11404376 - J Leukoc Biol. 2001 Jun;69(6):912-20
1398955 - Infect Immun. 1992 Oct;60(10):4427-9
15213139 - Infect Immun. 2004 Jul;72(7):3951-60
7642259 - Infect Immun. 1995 Sep;63(9):3302-8
11687239 - J Immunol Methods. 2001 Nov 1;257(1-2):55-69
15302901 - J Exp Med. 2004 Aug 16;200(4):437-45
2469934 - Microb Pathog. 1986 Aug;1(4):399-407
11331036 - J Interferon Cytokine Res. 2001 Mar;21(3):137-46
6185434 - Infect Immun. 1983 Jan;39(1):362-70
2956608 - Proc Natl Acad Sci U S A. 1987 Aug;84(16):5888-92
14634135 - J Immunol. 2003 Dec 1;171(11):6187-97
15614121 - Sex Transm Dis. 2005 Jan;32(1):49-56
8926054 - Infect Immun. 1996 Oct;64(10):3951-6
11349013 - Infect Immun. 2001 Jun;69(6):3556-61
15302899 - J Exp Med. 2004 Aug 16;200(4):527-33
9120292 - J Immunol. 1997 Apr 1;158(7):3344-52
9011579 - J Clin Invest. 1997 Jan 1;99(1):77-87
16299319 - Infect Immun. 2005 Dec;73(12):8226-36
17114470 - J Immunol. 2006 Dec 1;177(11):7974-9
16110316 - Nat Rev Immunol. 2005 Sep;5(9):675-87
15972679 - J Immunol. 2005 Jul 1;175(1):450-60
9234755 - Infect Immun. 1997 Aug;65(8):3065-73
16709859 - J Immunol. 2006 Jun 1;176(11):6982-90
3997251 - Infect Immun. 1985 Jun;48(3):847-9
18322213 - J Immunol. 2008 Mar 15;180(6):4040-9
18023394 - Microbes Infect. 2007 Nov-Dec;9(14-15):1561-6
11714812 - J Immunol. 2001 Dec 1;167(11):6453-61
11796619 - Infect Immun. 2002 Feb;70(2):844-50
16124999 - Curr Top Dev Biol. 2005;68:149-81
11083808 - Infect Immun. 2000 Dec;68(12):6879-82
1787004 - Immunol Cell Biol. 1991 Oct;69 ( Pt 5):337-48
12444163 - J Immunol. 2002 Dec 1;169(11):6522-9
14663124 - Sex Transm Infect. 2003 Dec;79(6):474-8
15187119 - J Immunol. 2004 Jun 15;172(12):7417-24
7228399 - Infect Immun. 1981 Mar;31(3):1161-76
7822016 - Infect Immun. 1995 Feb;63(2):516-21
8009221 - Science. 1994 Jun 24;264(5167):1918-21
11320211 - Proc Natl Acad Sci U S A. 2001 May 8;98(10):5752-7
e_1_3_2_27_2
e_1_3_2_28_2
e_1_3_2_29_2
e_1_3_2_41_2
e_1_3_2_40_2
e_1_3_2_20_2
e_1_3_2_43_2
e_1_3_2_21_2
e_1_3_2_42_2
e_1_3_2_22_2
e_1_3_2_23_2
e_1_3_2_24_2
e_1_3_2_25_2
e_1_3_2_9_2
e_1_3_2_15_2
e_1_3_2_38_2
e_1_3_2_8_2
e_1_3_2_16_2
e_1_3_2_37_2
e_1_3_2_7_2
e_1_3_2_17_2
e_1_3_2_6_2
e_1_3_2_18_2
e_1_3_2_39_2
e_1_3_2_19_2
(e_1_3_2_26_2) 1997; 158
e_1_3_2_30_2
e_1_3_2_32_2
e_1_3_2_10_2
e_1_3_2_31_2
e_1_3_2_5_2
e_1_3_2_34_2
e_1_3_2_4_2
e_1_3_2_12_2
e_1_3_2_33_2
e_1_3_2_3_2
e_1_3_2_13_2
e_1_3_2_36_2
e_1_3_2_2_2
e_1_3_2_14_2
e_1_3_2_35_2
(e_1_3_2_11_2) 2001; 69
References_xml – ident: e_1_3_2_4_2
  doi: 10.1016/S0022-1759(01)00446-X
– ident: e_1_3_2_37_2
  doi: 10.4049/jimmunol.169.11.6522
– ident: e_1_3_2_19_2
  doi: 10.1073/pnas.091096998
– ident: e_1_3_2_9_2
  doi: 10.4049/jimmunol.171.11.6187
– ident: e_1_3_2_14_2
  doi: 10.1016/j.micinf.2007.08.010
– ident: e_1_3_2_21_2
  doi: 10.1128/iai.63.12.4661-4668.1995
– ident: e_1_3_2_30_2
  doi: 10.1172/JCI119136
– ident: e_1_3_2_22_2
  doi: 10.1126/science.8009221
– ident: e_1_3_2_29_2
  doi: 10.1128/iai.48.3.847-849.1985
– ident: e_1_3_2_5_2
  doi: 10.1128/iai.31.3.1161-1176.1981
– ident: e_1_3_2_12_2
  doi: 10.1128/iai.64.10.3951-3956.1996
– ident: e_1_3_2_2_2
  doi: 10.1084/jem.20040976
– ident: e_1_3_2_3_2
  doi: 10.1128/IAI.70.2.844-850.2002
– ident: e_1_3_2_18_2
  doi: 10.1128/iai.63.2.516-521.1995
– volume: 158
  start-page: 3344
  year: 1997
  ident: e_1_3_2_26_2
  publication-title: J. Immunol.
– ident: e_1_3_2_38_2
  doi: 10.1128/iai.63.9.3302-3308.1995
– ident: e_1_3_2_35_2
  doi: 10.1016/j.cell.2007.10.034
– ident: e_1_3_2_32_2
  doi: 10.1128/iai.39.1.362-370.1983
– ident: e_1_3_2_10_2
  doi: 10.1038/nri1684
– ident: e_1_3_2_36_2
  doi: 10.1097/01.olq.0000148299.14513.11
– ident: e_1_3_2_6_2
  doi: 10.1128/IAI.68.12.6879-6882.2000
– volume: 69
  start-page: 912
  year: 2001
  ident: e_1_3_2_11_2
  publication-title: J. Leukoc. Biol.
– ident: e_1_3_2_17_2
  doi: 10.1016/S0070-2153(05)68006-4
– ident: e_1_3_2_15_2
  doi: 10.1128/IAI.72.7.3951-3960.2004
– ident: e_1_3_2_7_2
  doi: 10.1128/iai.65.8.3065-3073.1997
– ident: e_1_3_2_16_2
  doi: 10.1073/pnas.84.16.5888
– ident: e_1_3_2_42_2
  doi: 10.1089/107999001750133131
– ident: e_1_3_2_24_2
  doi: 10.1073/pnas.0607325103
– ident: e_1_3_2_28_2
  doi: 10.1128/iai.60.10.4427-4429.1992
– ident: e_1_3_2_31_2
  doi: 10.4049/jimmunol.177.11.7974
– ident: e_1_3_2_40_2
  doi: 10.4049/jimmunol.172.12.7417
– ident: e_1_3_2_13_2
  doi: 10.1038/icb.1991.49
– ident: e_1_3_2_23_2
  doi: 10.4049/jimmunol.175.1.450
– ident: e_1_3_2_33_2
  doi: 10.4049/jimmunol.167.11.6453
– ident: e_1_3_2_41_2
  doi: 10.4049/jimmunol.180.6.4040
– ident: e_1_3_2_43_2
  doi: 10.1128/IAI.73.12.8226-8236.2005
– ident: e_1_3_2_27_2
  doi: 10.1089/jir.2006.26.699
– ident: e_1_3_2_39_2
  doi: 10.1016/0882-4010(86)90071-9
– ident: e_1_3_2_34_2
  doi: 10.4049/jimmunol.176.11.6982
– ident: e_1_3_2_25_2
  doi: 10.1084/jem.20040712
– ident: e_1_3_2_20_2
  doi: 10.1136/sti.79.6.474
– ident: e_1_3_2_8_2
  doi: 10.1128/IAI.69.6.3556-3561.2001
SSID ssj0014448
Score 2.2998292
Snippet Type I interferons (IFNs) induced during in vitro chlamydial infection exert bactericidal and immunomodulatory functions. To determine the precise role of type...
Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit...
ABSTRACT Type I interferons (IFNs) induced during in vitro chlamydial infection exert bactericidal and immunomodulatory functions. To determine the precise...
SourceID pubmedcentral
proquest
crossref
pubmed
pascalfrancis
highwire
fao
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 4642
SubjectTerms Animals
Bacterial Infections
Biological and medical sciences
Chemokine CXCL10 - biosynthesis
Chemokine CXCL9 - biosynthesis
Chlamydia
Chlamydia Infections - immunology
Chlamydia muridarum - immunology
Colony Count, Microbial
Female
Female Urogenital Diseases - microbiology
Female Urogenital Diseases - pathology
Fundamental and applied biological sciences. Psychology
Interferon Type I - immunology
Lymph Nodes - immunology
Mice
Mice, Inbred C57BL
Mice, Knockout
Microbiology
Receptor, Interferon alpha-beta - deficiency
T-Lymphocytes - immunology
Title Type I Interferon Signaling Exacerbates Chlamydia muridarum Genital Infection in a Murine Model
URI http://iai.asm.org/content/76/10/4642.abstract
https://www.ncbi.nlm.nih.gov/pubmed/18663004
https://search.proquest.com/docview/19643798
https://search.proquest.com/docview/21495858
https://search.proquest.com/docview/69571313
https://pubmed.ncbi.nlm.nih.gov/PMC2546839
Volume 76
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwEB11K4G4VFA-GgqLD3BMd-PEjn2sVi1d0CJQWak3y4mdbaTGW-2HRP89YycpXQQcOMdObM_Yfs-evAF4zyurGXLp2Fhh4yyzJi6qMo2LJC-0toWUpT_vmH3hF_Ps0xW72gPW_wsTgvbLoj5xN82Jq69DbOVtU476OLHR19nEa7jjxj4awAAdtKfo3dVBlmXd8itjBP95H-1OxWh6OvVxXFTG45CnT_AgOLWzJQ0qvXwgFuxjJfUah6tq81z8CYj-Hk_5YIM6fwoHHbIkp20PnsGedYfwqM01eXcIj2fdLfpzUJ58kikJp4GVXS0duawXHpG7BTn7oUscag9ByeQa_eUOPYg021Vt9GrbkI_W-TwjWLmN4nKkdkSTmT-1t8SnVrt5AfPzs--Ti7hLtBCXjLJNbJHDZCaxlOdaWi9xZ9PEaKk5ZyZhWhZphfM4ZWMupOBlOa6MLGme4xKFm6BMX8K-Wzp7BCSXGiEFSywCT6RuUhbSaGtwzEVRMW0i-NCPtbpt9TRU4CFUKDSPCuZRYxHBERpC6QUudWp-Sf0FK6I9RGhpBMe9dZReN6rWtcq5f0uGZCqC4Y7B7r9CsfFpmmYRvOstqHAq-fsR7exyu1ZBmyyX4u8lqOeTgv2jBJcMaX-CjXzV-sSvXnbeFkG-4y33BbzQ9-4T9P8g-N35--v_rnkMT2iv45u8gf3NamvfIpjaFEMYfP4mhmEK_QSUjhzS
link.rule.ids 230,315,730,783,787,888,27936,27937,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwEB21RXxcEBRKQ6H1AY7pJk7sxMdq1bIL3QqpXak3y4mdbaTGW-2HRP89YycpXQQcOMdJHM-M_Z49eQPwiVdGMeTSoTa5CdPU6LCoyiQs4qxQyhRClG6_Y3LBR9P06zW73gLW_wvjk_bLoj62t82xrW98buVdUw76PLHB98nQabjjwj7YhicYr1Hak_Tu8CBN024CFiHC_6zPd6f5YHwydplcVISRr9SXcy85tbEobVdq_kgu2GVLqiUOWNVWuvgTFP09o_LREnX2Cl522JKctN_wGraM3YWnbbXJ-114NunO0d-AdPSTjInfD6zMYm7JZT1zmNzOyOkPVeJgOxBKhjfoMffoQ6RZL2qtFuuGfDHWVRrBm9s8LktqSxSZuH17Q1xxtdu3MD07vRqOwq7UQlgyylahQRaT6thQnilhnMidSWKthOKc6ZgpUSQVRnLCIp6LnJdlVGlR0izDSQqXQZHswY6dW7MPJBMKQQWLDUJPJG9CFEIro3HM86JiSgfwuR9redcqakjPRGgu0TzSm0dGeQD7aAipZjjZyekldUesiPcQoyUBHPTWkWrZyFrVMuPuKSnSqQAONwz28BaKnU-SJA3gqLegxGByJyTKmvl6Kb06WSbyv7egjlHm7B8tuGBI_GPs5LvWJ359ZedtAWQb3vLQwEl9b17BCPCS353Hv__vO4_g-ehqci7PxxffDuAF7VV94w-ws1qszUeEVqvi0AfSTwEWHzM
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELVoERWXCspHQ6H1AY5pEid27GO1dOkCW1UqK_VmObGzjdR4V_sh0X_fsZOUXQQcOMdJbM-M_Z49eoPQR1YZRYFLh9pwE2aZ0WFRlWlYJHmhlCmEKN15x_iSXUyyrzf0ZqPUl0_aL4v61N41p7a-9bmV86aM-jyx6Go8cBrusLFHc11FO-gpxGzMeqLeXSBkWdYtwiIECpD3Oe-ER6OzkcvmIiKMfbU-zrzs1NbGtFOp2YZksMuYVEuYtKqtdvEnOPp7VuXGNjV8gfY7fInP2nG8RE-MPUDP2oqT9wdob9zdpb9C0lFQPML-TLAyi5nF1_XU4XI7xec_VQkT7oAoHtyC19yDH-Fmvai1Wqwb_MVYV20EXm5zuSyuLVZ47M7uDXYF1u5eo8nw_MfgIuzKLYQlJXQVGmAymU4MYbkSxgndmTTRSijGqE6oEkVaQTSnNGZccFaWcaVFSfIcFirYCkX6Bu3amTWHCOdCAbCgiQH4CQROiEJoZTTMOS8qqnSAPvVzLeetqob0bIRwCeaR3jwy5gE6BENINYUFT06uibtmBcwHOC0N0FFvHamWjaxVLXPmvpIBpQrQ8ZbBHv9CoPNpmmYBOuktKCGg3C2Jsma2XkqvUJYL_vcWxLFKTv_RggkK5D-BTr5tfeLXKDtvC1C-5S2PDZzc9_YTiAIv-915_bv_fvME7V19Hsrvo8tvR-g56YV9k_dod7VYmw-ArlbFsY-jBykZIEY
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Type+I+Interferon+Signaling+Exacerbates+Chlamydia+muridarum+Genital+Infection+in+a+Murine+Model&rft.jtitle=Infection+and+immunity&rft.au=NAGARAJAN%2C+Uma+M&rft.au=PRANTNER%2C+Daniel&rft.au=SIKES%2C+James+D&rft.au=ANDREWS%2C+Charles+W&rft.date=2008-10-01&rft.pub=American+Society+for+Microbiology&rft.issn=0019-9567&rft.eissn=1098-5522&rft.volume=76&rft.issue=10&rft.spage=4642&rft.epage=4648&rft_id=info:doi/10.1128%2FIAI.00629-08&rft.externalDBID=n%2Fa&rft.externalDocID=20683334
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0019-9567&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0019-9567&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0019-9567&client=summon